The effects of cardiopulmonary bypass on plasma concentrations and protein binding of methohexital and thiopental

Journal of Cardiothoracic Anesthesia - Tập 2 - Trang 281-289 - 1988
Andrew R. Bjorksten1,2,3, David P. Crankshaw1,2,3, Denis J. Morgan1,2,3, Peter R. Prideaux1,2,3
1From the Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Victorian College of Pharmacy Ltd, Victoria, Australia
2From the Department of Anaesthetics, Amalgamated Melbourne and Essendon Hospitals; Victorian College of Pharmacy Ltd, Victoria, Australia
3From the Department of Pharmaceutics, Victorian College of Pharmacy Ltd, Victoria, Australia

Tài liệu tham khảo

Bovill, 1984, Opioid analgesics in anesthesia: With special reference to their use in cardiovascular anesthesia, Anesthesiology, 61, 731, 10.1097/00000542-198412000-00018 Nussmeier, 1986, Neuropsychiatric complications after cardiopulmonary bypass: Cerebral protection by a barbiturate, Anesthesiology, 64, 165, 10.1097/00000542-198602000-00006 Nehls, 1987, A comparison of the cerebral protective effects of isoflurane and barbiturates during temporary focal ischemia in primates, Anesthesiology, 66, 453, 10.1097/00000542-198704000-00002 Hudson, 1983, Pharmacokinetics of methohexital and thiopental in surgical patients, Anesthesiology, 59, 215 Chan, 1985, Pentobarbitone formation during thiopentone infusion, Anesthesia, 40, 1155, 10.1111/j.1365-2044.1985.tb10650.x Holley, 1982, Effect of cardiopulmonary bypass on the disposition of drugs, Clin Pharmacokinet, 7, 234, 10.2165/00003088-198207030-00004 Shanks, 1983, Gallamine disposition in open heart surgery involving cardiopulmonary bypass, Clin Pharmacol Ther, 33, 792, 10.1038/clpt.1983.108 Walker, 1983, Alcuronium kinetics in patients undergoing cardiopulmonary bypass surgery, Br J Clin Pharmacol, 15, 237, 10.1111/j.1365-2125.1983.tb01492.x Miller, 1979, Cephalothin kinetics: Before, during and after cardiopulmonary bypass surgery, Clin Pharmacol Ther, 26, 54, 10.1002/cpt197926154 Walker, 1984, Altered d-tubocurarine disposition during cardiopulmonary bypass surgery, Clin Pharmacol Ther, 35, 686, 10.1038/clpt.1984.96 d'Hollander, 1983, Variations in pancuronium requirement, plasma concentration, and urinary excretion induced by cardiopulmonary bypass with hypothermia, Anesthesiology, 58, 505, 10.1097/00000542-198306000-00004 Plachetka, 1981, Plasma propranolol before, during and after cardiopulmonary bypass, Clin Pharmacol Ther, 30, 745, 10.1038/clpt.1981.233 Storstein, 1979, Effect of cardiopulmonary bypass with heparin administration on digitoxin pharmacokinetics, serum electrolytes, free fatty acids, and renal function, J Cardiovasc Pharmacol, 1, 191, 10.1097/00005344-197903000-00003 Miller, 1980, Effect of cardiopulmonary bypass on cefazolin disposition, Clin Pharmacol Ther, 27, 550, 10.1038/clpt.1980.78 Koren, 1984, Pediatric fentanyl dosing based on pharmacokinetics during cardiac surgery, Anesth Analg, 63, 577, 10.1213/00000539-198406000-00005 Morgan, 1986, Thiopentone levels during cardiopulmonary bypass. Changes in plasma protein binding during continuous infusion, Anaesthesia, 41, 4, 10.1111/j.1365-2044.1986.tb12695.x James, 1976 Crankshaw, 1987, Plasma drug efflux: A new approach to optimization of drug infusion for constant blood concentration of thiopental and methohexital, Anesthesiology, 67, 32, 10.1097/00000542-198707000-00006 Christensen, 1983, The binding of thiopental to human serum albumin at variable pH and temperature, Acta Pharmacol Toxicol, 52, 364, 10.1111/j.1600-0773.1983.tb01116.x Miller, 1981 Ghoneim, 1976, Binding of thiopental to plasma proteins: Effects on distribution in the brain and heart, Anesthesiology, 45, 635, 10.1097/00000542-197612000-00008 Mark, 1968, Studies with thiohexital, an anesthetic barbiturate metabolized with unusual rapidity in man, Anesthesiology, 29, 1159, 10.1097/00000542-196811000-00013 Csogor SI, Kerek SF: Enhancement of thiopentone anaesthesia by sulphafurazole. Br J Anaesth 42:988–990 Chaplin, 1973, Displacement of thiopental from plasma proteins by nonsteroid anti-inflammatory agents, 143, 671 McDevitt, 1976, Plasma binding and the affinity of propranolol for a beta-receptor in man, Clin Pharmacol Ther, 20, 152, 10.1002/cpt1976202152 Borga, 1970, The role of protein binding in the inhibitory effect of nortriptyline on the neuronal uptake of norepinephrine, Clin Pharmacol Ther, 11, 581, 10.1002/cpt1970114581 Kunin, 1973, Influence of binding on the pharmacologic activity of antibiotics, Ann NY Acad Sci, 226, 214, 10.1111/j.1749-6632.1973.tb20483.x Reves, 1981, Influence of serum protein, serum albumin concentrations, and dose on midazolam anaesthesia induction times, Can Anaesth Soc J, 28, 556, 10.1007/BF03007152 Denson, 1984, The relationship between free bupivacaine concentration and central nervous system toxicity, Anesthesiology, 60, A211, 10.1097/00000542-198409001-00211 Booker, 1973, Serum concentrations of free diphenylhydantoin and their relationship to clinical intoxication, Epilepsia, 14, 177, 10.1111/j.1528-1157.1973.tb03954.x Lund, 1971, Plasma binding of diphenylhydantoin in patients with epilepsy. Agreement between the unbound fraction in plasma and the concentra tion in cerebrospinal fluid, Clin Pharmacol Ther, 13, 196, 10.1002/cpt1972132196 Burch, 1983, The role of metabolism and protein binding in thiopental anesthesia, Anesthesiology, 58, 146, 10.1097/00000542-198302000-00008